Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents

QR Code

Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Anti-Neoplastic Agents

None

Saved in:

Bibliographic Details
Main Authors:	Lexcen, Daniel, Salem, Ahmed, El-Khatib, Walid M., Haynes, Virginia, Noreddin, Ayman
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/35689
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Application of Pharmacokinetics/Pharmacodynamics (PK/PD) in Designing Effective Antibiotic Treatment Regimens
by: Ahmed, Ghada F., et al.
Published: (2012)

Pharmacokinetic (PK) and Pharmacodynamic Profiles of Artemisinin Derivatives Influence Drug Neurotoxicity in Animals
by: Li, Qigui, et al.
Published: (2012)

Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
by: Anca Dragomirescu,, et al.
Published: (2008-12-01)

Pharmacokinetic – Pharmacodynamic Considerations for Bovine Mastitis Treatment
by: Mestorino, Nora, et al.
Published: (2012)

10th anniversary of the journal «Pharmacokinetics and pharmacodynamics»
by: V. P. Zherdev
Published: (2014-04-01)

Assessment of pharmacokinetics-pharmacodynamics relationship of tropoxine in rats
by: V. P. Zherdev, et al.
Published: (2016-09-01)

On the 20th anniversary of the journal «Pharmacokinetics and Pharmacodynamics»
by: V. P. Zherdev
Published: (2024-06-01)

Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients After Renal Transplantation
by: Rath, Thomas, et al.
Published: (2012)

Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions
by: Joshuaine Grant, et al.
Published: (2023-12-01)

Pharmacokinetics/pharmacodynamics of antibiotics with different protein binding rates in hemodialysis
by: SHEN Yue, et al.
Published: (2025-06-01)

PK/PD Modeling as a Tool for Predicting Bacterial Resistance to Antibiotics: Alternative Analyses of Experimental Data
by: M. V. Golikova, et al.
Published: (2020-05-01)

Time‐varying covariates, overadjustment bias and mediation in pharmacokinetic/pharmacodynamic modeling
by: Sebastiaan Camiel Goulooze, et al.
Published: (2024-08-01)

Population Pharmacokinetics and Pharmacodynamics with Enterohepatic Recirculation of Co-Medication of Rosuvastatin and Ezetimibe
by: An H, et al.
Published: (2025-06-01)

Pharmacokinetic and Pharmacodynamic Modeling of Enrofloxacin and Its Metabolite Ciprofloxacin in Pregnant Goats
by: Luis Adrian Ambros, et al.
Published: (2025-06-01)

A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin.
by: Songie Choi, et al.
Published: (2017-01-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)

Evaluating PK/PD Relationship of CNS Drug by Using Liquid Chromtography/ Tandem Mass Spectrometry Coupled to In Vivo Microdialysis
by: Qu, Ying, et al.
Published: (2012)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

Compliance of extended infusion of piperacillin/tazobactam with the desired pharmacokinetic/pharmacodynamic index in septic patients
by: Tomić Nataša, et al.
Published: (2025-01-01)

Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors
by: Łukasz Wołowiec, et al.
Published: (2025-07-01)

CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE
by: O. D. Ostroumova, et al.
Published: (2017-09-01)

In Vivo PK-PD and Drug–Drug Interaction Study of Dorzagliatin for the Management of PI3Kα Inhibitor-Induced Hyperglycemia
by: Guanqin Jin, et al.
Published: (2025-06-01)

Inhibition of Adhesion and Invasion of Pseudomonas aeruginosa to Lung Epithelial Cells: A Model of Cystic Fibrosis Infection
by: Noreddin, Ayman M., et al.
Published: (2012)

Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against Streptococcus uberis in vitro dynamic model
by: Chongyang Li, et al.
Published: (2025-07-01)

Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism
by: Hui Li, et al.
Published: (2025-06-01)

Investigation of the <i>ABCB1</i> Gene Polymorphism and Food Effects on the Avatrombopag Pharmacokinetics in Chinese Individuals: A Population Pharmacokinetic/Pharmacodynamic Analysis
by: Xin Liu, et al.
Published: (2025-06-01)

Actin isoforms and neoplastic transformation
by: V. B. Dugina, et al.
Published: (2017-04-01)

Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
by: S. B. Fitilev, et al.
Published: (2022-03-01)

Ferulic Acid as an Anti-Inflammatory Agent: Insights into Molecular Mechanisms, Pharmacokinetics and Applications
by: Jiaying Liu, et al.
Published: (2025-06-01)

PHARMACOKINETICS/PHARMACODYNAMICS OF A 8-LACTAM AND /8-LACTAMASE INHIBITOR COMBINATION: A NOVEL APPROACH FOR AZTREONAM/AVIBACTAM
by: R. .. Singh, et al.
Published: (2020-05-01)

Pharmacokinetic/pharmacodynamic relationship of a novel pleuromutilin derivative p-furoylamphenmulin against Mycoplasma gallisepticum in vivo in chickens
by: Xirui Xia, et al.
Published: (2025-08-01)

A physiologically‐based pharmacokinetic/pharmacodynamic modeling approach for drug–drug‐gene interaction evaluation of S‐warfarin with fluconazole
by: Kuo Geng, et al.
Published: (2024-05-01)

Impact of Renal Impairment on the Pharmacodynamic and Pharmacokinetic Profiles of Epaminurad, a Novel Uric Acid Transporter 1 Inhibitor
by: Seo Yeong Park, et al.
Published: (2025-06-01)

PRE-NEOPLASTIC AND NEOPLASTIC CHANGES IN BRONCHIAL EPITHELIUM OF PATIENTS WITH SQUAMOUS CELL LUNG CANCER AND LUNG ADENOCARCINOMA
by: O. V. Pankova, et al.
Published: (2014-06-01)

Pharmacokinetics, Pharmacodynamic, Safety and Tolerability of Fazamorexant, a Novel Dual Orexin Receptor Antagonist: Report of the First-in-Human Study
by: Ni J, et al.
Published: (2025-06-01)

Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors
by: Sho Yoshimoto, et al.
Published: (2023-12-01)

Results of a double-blind, randomized, comparative, cross-sectional study of the pharmacokinetics and pharmacodynamics of genetically engineered human insulin preparations
by: Alexander Mayorov, et al.
Published: (2019-09-01)

A Comparison of in-vitro Pharmacokinetics and Pharmacodynamics of Branded and Its Locally Produced Cefuroxime Sodium Against Staphylococcus and Escherichia Escherichia coli
by: Du M, et al.
Published: (2025-06-01)

Fermentative Production of 1,3;1,6-β-D-Glucan (Translam), a Labeled Immunostimulant and Investigation of Its Pharmacokinetics and Pharmacodynamics
by: T. N. Zvyagintseva, et al.
Published: (2020-05-01)

Modeling the Influence of <i>CYP2C9</i> and <i>ABCB1</i> Gene Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Losartan
by: Dmitry Babaev, et al.
Published: (2025-07-01)